In an interview with Targeted Oncology, Lucio N. Gordan, MD, Florida Cancer Specialists & Research Institute, proposes a ...
Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback